Status:
COMPLETED
Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
Lead Sponsor:
Galderma R&D
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
This was a multi-center, randomized, double-blind, parallel group study with 12 weeks of treatment of acne vulgaris. Efficacy and safety evaluations were performed at Screening (safety only), Baseline...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- A clinical diagnosis of acne vulgaris with facial involvement.
- A minimum of 20 but not more than 50 inflammatory lesions
- A minimum of 30 but not more than 100 noninflammatory lesions
- A score of 3 (Moderate) on the Investigator's Global Assessment Scale
Exclusion
Key Trial Info
Start Date :
June 27 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2007
Estimated Enrollment :
1668 Patients enrolled
Trial Details
Trial ID
NCT00422240
Start Date
June 27 2006
End Date
July 12 2007
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miller MD
San Antonio, Texas, United States, 78229